老虎证券

美股详情
本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Alterity Therapeutics Limited

3.50
+0.10002.94%
盘后：3.500.00000.00%16:07 EDT
成交量：9,069.00
成交额：3.10万
市值：5,181.19万
市盈率：-2.38
高：3.50
开：3.43
低：3.31
收：3.40
数据加载中...
总览公司新闻公告
2024/09/26

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2023/08/31

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2022/10/31

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/08/31

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2022/08/26

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/08/01

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/07/21

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/03/28

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/03/04

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/07/08

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/01/04

SEC问询函

CORRESP [Cover] - Correspondence
2020/12/02

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2020/11/25

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/11/19

SEC问询函

CORRESP [Cover] - Correspondence
2020/10/26

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/10/08

SEC问询函

CORRESP [Cover] - Correspondence
2020/09/23

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2020/09/15

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2020/07/06

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/03/27

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
更多